Cinven

News, insights, analysis and data

← Back to Cinven profile

Cinven related stories

All articles and analysis

  • PEI Awards 2015 EMEA: winning big
    Victoria Robson- 2 March 2016

    Among the winners in this region were CVC Capital Partners, which took two key awards, EQT, PGGM, Apax and Abraaj.

  • LP Radar - March 2016
    PEI Staff- 1 March 2016

    See the latest PE LP updates, including allocation changes and people moves.

  • Impetus-PEF unveils 2016 vision
    Victoria Robson- 26 February 2016

    The charity focused on supporting disadvantaged young people will initiate a new project in March looking at the barriers to education and employment.

  • Inflexion boosts value creation team
    Isobel Markham- 24 February 2016

    The UK mid-market firm has appointed Tom Green as its second value enhancement director to support strategic and operational value creation within its portfolio companies.

  • Bain agrees to sell Brakes to Sysco for $3.1bn
    Annabelle Ju- 22 February 2016

    The firm initially acquired the food distributor from Clayton Dubilier & Rice in 2007 for about $1.75bn.

  • Equistone takes second bite at Gaucho
    Isobel Markham- 19 January 2016

    The mid-market private equity firm has invested in the Argentine steak restaurant for the second time in a deal reported to value the chain at £100m.

  • Impetus-PEF appoints new chief exec
    Victoria Robson- 19 January 2016

    Andrew Ratcliffe joins the youth-focused charity from the Africa Governance Initiative.

  • Cinven eyes US medtech firms looking to Europe
    PEI Staff- 18 January 2016

    Cinven currently has just two healthcare investments: Labco, and US pharma contract research group Medpace, which it acquired for $915 million in 2014.

  • BC Partners launches €7bn Fund X
    Victoria Robson- 13 January 2016

    The firm has sent a PPM to investors for its latest vehicle.

  • Cinven promotes healthcare partner
    Matthew Goodburn- 8 January 2016

    Leslie was also involved in last October’s £2.3 billion ($3.4 million; €3.1 million) sale of generic drugmaker AMCo to Concordia.